Europe Biobanks Market Size (2024 - 2029)

The European biobanks market is experiencing growth driven by the increasing adoption of stem cell therapies and advancements in regenerative medicine. Biobanks play a crucial role in preserving stem cells, such as umbilical cord cells, which are essential for developing treatments for various diseases, including Alzheimer's, diabetes, cancer, and rare genetic disorders. The market size is further influenced by the rising awareness and demand for stem cell therapies, as well as the support from organizations like the European Science Foundation in research and treatment development. Additionally, the growing burden of chronic diseases and increased R&D funding from both governmental and non-governmental entities are key factors contributing to the expansion of the market.

Home Market Analysis Healthcare Research Biotechnology Research Bioservices Research Biobanks Research Europe Biobanks Market Market Size

Market Size of Europe Biobanks Industry

CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 6.50 %

Major Players

Europe Biobanks Market Major Players

*Disclaimer: Major Players sorted in no particular order

Europe Biobanks Market Analysis

Stem cell practices are on the rise in European countries and are contributing to the development of new solutions for various diseases. Several advancements have been made in regenerative medicine through stem cell technology over the past decade. Thus, it has become one of the vital treatment methods for diseases, such as Alzheimer's, diabetes, cancer, and rare genetic diseases. To benefit from the existing therapies, umbilical cord cells and other stem cells are preserved in Biobanks. The European Science Foundation (ESF) has been an active player in advancements made in stem cell and regenerative medicine research and in providing new treatments for incurable diseases and opportunities. With the increase in awareness about stem cell therapies, there have been a larger number of parents, who choose umbilical cord banks for their children. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. However, other factors such as rising burden of chronic diseases and R&D funding and investments by government and non-governmental organizations are also expected to drive the market in the forecast period.

Europe Biobanks Industry Segmentation

As per the scope of the report, Biobanks are the bio-repository, wherein various biomaterials (usually human specimens) are stored for research purposes. This study targets gaining a detailed overview of the market dynamics of the contemporary biobank market during the forecast period. 

Equipment
Cryogenic Storage Systems
Refrigerators
Ice Machines
Freezers
Alarm Monitoring Systems
Other Equipment
Media
Optimized Media
Non-optimized Media
Services
Human Tissue Biobanking
Stem Cell Biobanking
Cord Banking
DNA/RNA Biobanking
Other Services
By Application
Regenerative Medicine
Drug Discovery
Disease Research
Need A Different Region Or Segment?
Customize Now

Europe Biobanks Market Size Summary

The European biobanks market is experiencing significant growth, driven by the increasing adoption of stem cell practices and advancements in regenerative medicine. This sector plays a crucial role in developing new treatments for various diseases, including Alzheimer's, diabetes, cancer, and rare genetic disorders. Biobanks are essential for preserving umbilical cord cells and other stem cells, which are vital for these therapies. The European Science Foundation has been instrumental in promoting research and providing new treatment opportunities, further boosting market expansion. The growing awareness and preference for stem cell therapies among parents opting for umbilical cord banking are also contributing to market growth. Additionally, the rising prevalence of chronic diseases and increased funding for research and development by both governmental and non-governmental organizations are expected to drive the market forward.

The market is characterized by a competitive landscape, with key players such as Atlanta Biologicals Inc., Becton, Dickinson and Company, BioLifeSolutions Inc., Hamilton Company, Qiagen N.V., Stemcell Technologies Inc., and Thermo Fisher Scientific leading the charge. These companies are instrumental in providing essential equipment and technologies, including cryogenic storage systems and alarm monitoring systems, which are crucial for the effective operation of biobanks. The demand for automated storage systems and advanced monitoring devices is on the rise, fueled by technological advancements and the need for continuous process monitoring. This competitive environment, coupled with the entry of new players, is expected to further stimulate market growth in the coming years.

Explore More

Europe Biobanks Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Advancements in Stem Cell and Regenerative Medicine Research

      2. 1.2.2 Rising Burden of Chronic Diseases

      3. 1.2.3 R&D Funding and Investments by Government and Non-Governmental Organizations

    3. 1.3 Market Restraints

      1. 1.3.1 Regulatory Issues

      2. 1.3.2 Cost Constraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Equipment

      1. 2.1.1 Cryogenic Storage Systems

        1. 2.1.1.1 Refrigerators

        2. 2.1.1.2 Ice Machines

        3. 2.1.1.3 Freezers

      2. 2.1.2 Alarm Monitoring Systems

      3. 2.1.3 Other Equipment

    2. 2.2 Media

      1. 2.2.1 Optimized Media

      2. 2.2.2 Non-optimized Media

    3. 2.3 Services

      1. 2.3.1 Human Tissue Biobanking

      2. 2.3.2 Stem Cell Biobanking

      3. 2.3.3 Cord Banking

      4. 2.3.4 DNA/RNA Biobanking

      5. 2.3.5 Other Services

    4. 2.4 By Application

      1. 2.4.1 Regenerative Medicine

      2. 2.4.2 Drug Discovery

      3. 2.4.3 Disease Research

Europe Biobanks Market Size FAQs

The Europe Biobanks Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

BioLifeSolutions Inc., Hamilton Company, Sigma-Aldrich Inc. (Merck KGaA), Thermo Fisher Scientific Inc. and VWR International LLC are the major companies operating in the Europe Biobanks Market.

Europe Biobanks Report Snapshots

Europe Biobanks Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)